Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Arcutis Biotherapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- 0 vs. Q2 2023
- Shares held
- 67.2M
- −3.13M (−4.5%) vs. Q2 2023
- Total value
- $356.7M
- −$313.2M (−46.8%) vs. Q2 2023
- New holders
- 18
- 54 more added
- Sold out
- 18
- 37 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 219,177 | $1.16M | 0.00% | +6,481+3.0% | Added |
| Morgan Stanley | 222,040 | $1.18M | 0.00% | −263,938−54.3% | Reduced |
| Bank of New York Mellon Corp | 237,779 | $1.26M | 0.00% | +27,170+12.9% | Added |
| Citadel Advisors LLC | 250,535 | $1.33M | 0.00% | +196,127+360.5% | Added |
| Parallax Volatility Advisers, L.P. | 282,434 | $1.50M | 0.05% | +22,578+8.7% | Added |
| Millennium Management LLC | 308,949 | $1.64M | 0.00% | +308,949 | New |
| Tejara Capital Ltd | 309,179 | $1.64M | 0.93% | +145,000+88.3% | Added |
| Goldman Sachs Group Inc | 333,010 | $1.77M | 0.00% | −361,311−52.0% | Reduced |
| Bank of America Corp | 350,963 | $1.86M | 0.00% | −55,592−13.7% | Reduced |
| Prudential Financial Inc | 363,415 | $2.01M | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 383,813 | $2.04M | 0.00% | +53,871+16.3% | Added |
| Rafferty Asset Management, LLC | 419,309 | $2.23M | 0.01% | −80,613−16.1% | Reduced |
| Northern Trust Corp | 483,499 | $2.57M | 0.00% | +17,846+3.8% | Added |
| American Century Companies Inc | 510,094 | $2.71M | 0.00% | +2150.0% | Added |
| Sio Capital Management, LLC | 635,969 | $3.38M | 1.05% | +342,922+117.0% | Added |
| Ensign Peak Advisors, Inc | 826,095 | $4.39M | 0.01% | −6,445−0.8% | Reduced |
| Geode Capital Management, LLC | 1,037,946 | $5.51M | 0.00% | +100,499+10.7% | Added |
| Woodline Partners LP | 1,104,244 | $5.86M | 0.07% | +296,494+36.7% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5.87M | 2.34% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 1,135,227 | $6.03M | 0.33% | +262,800+30.1% | Added |
| Holocene Advisors, LP | 1,204,538 | $6.40M | 0.03% | −235,498−16.4% | Reduced |
| Franklin Resources Inc | 1,292,353 | $6.86M | 0.00% | −360,183−21.8% | Reduced |
| OrbiMed Advisors LLC | 1,914,479 | $10.2M | 0.24% | 00.0% | Unchanged |
| GW&K Investment Management, LLC | 2,069,293 | $11.0M | 0.11% | +6,610+0.3% | Added |
| Marshall Wace, LLP | 2,311,077 | $12.3M | 0.03% | −6,464−0.3% | Reduced |
| Vanguard Group Inc | 2,879,460 | $15.3M | 0.00% | +229,072+8.6% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15.9M | 1.78% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 3,117,944 | $16.6M | 0.12% | −9,833−0.3% | Reduced |
| BlackRock Inc. | 4,020,401 | $21.3M | 0.00% | −210,973−5.0% | Reduced |
| State Street Corp | 4,360,807 | $23.2M | 0.00% | −865,202−16.6% | Reduced |
| Jennison Associates LLC | 4,432,175 | $23.5M | 0.02% | +138,209+3.2% | Added |
| Rubric Capital Management LP | 5,034,530 | $26.7M | 1.12% | +150,000+3.1% | Added |
| FMR LLC | 8,262,042 | $43.9M | 0.00% | −950,744−10.3% | Reduced |
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46.1M | 3.07% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −448,642−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −337,052−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −241,846−100.0% | Sold out |
| 1492 Capital Management LLC | 0 | $0 | 0.00% | −222,767−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −96,600−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −82,000−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −56,903−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −28,414−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,769−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,631−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −10,304−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,379−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Tekla Capital Management LLC | – | – | – | – | Not filed |